Published in J Neurol Sci on May 01, 1990
Cardiovascular dementia - a different perspective. Open Biochem J (2010) 0.83
Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus. PLoS One (2013) 0.81
Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Br J Pharmacol (1993) 0.81
Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801, a standardized dioscorea extract for diabetic neuropathy, in human in vitro and rat in vivo. BMC Complement Altern Med (2014) 0.79
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
A flow-sensitive apparatus for studying the responses of the constrictor muscles of perfused tubular organs [proceedings]. J Physiol (1978) 2.14
Preventing the spread of HIV infection. BMJ (1991) 1.88
The distribution and axonal transport of free amino acids and related compounds in the dorsal sensory neuron of the rat, as determined by the dansyl reaction. J Neurochem (1973) 1.70
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci (1994) 1.50
Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia (1993) 1.44
Complexes of the G protein subunit gbeta 5 with the regulators of G protein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells. J Biol Chem (2000) 1.39
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia (1983) 1.21
A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain (1998) 1.20
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes (1999) 1.16
Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res (1993) 1.10
A light-scattering technique for the study of the permeability of rat brain synaptosomes in vitro. J Neurochem (1970) 1.10
Is aflatoxin carcinogenic in man? The evidence in Swaziland. Trop Geogr Med (1971) 1.10
An ultrastructural classification of the neuronal cell bodies of the rat dorsal root ganglion using zinc iodide-osmium impregnation. Cell Tissue Res (1977) 1.06
The role of internal and external Na+ and K+ on the uptake of [3H] noradrenaline by synaptosomes prepared from rat brain. Biochim Biophys Acta (1970) 1.06
Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Mol Endocrinol (2011) 1.05
The permeability of pinched-off nerve endings to sodium, potassium and chloride and the effects of gramicidin. J Neurochem (1971) 1.03
Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes (1984) 1.03
Phosphorylation of the Gq/11-coupled m3-muscarinic receptor is involved in receptor activation of the ERK-1/2 mitogen-activated protein kinase pathway. J Biol Chem (2000) 1.03
Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage granules. J Physiol (1971) 1.03
Single-cell imaging of graded Ins(1,4,5)P3 production following G-protein-coupled-receptor activation. Biochem J (2001) 1.02
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia (1983) 1.00
Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci (1995) 0.98
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Desensitization of gonadotropin-releasing hormone action in alphaT3-1 cells due to uncoupling of inositol 1,4,5-trisphosphate generation and Ca2+ mobilization. J Biol Chem (1996) 0.96
Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits. J Physiol (2007) 0.96
Decline of tissue noradrenaline under the influence of a mitotic inhibitor. Nature (1970) 0.95
A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia (1999) 0.94
Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia (1994) 0.94
Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci (2001) 0.93
Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization. Mol Pharmacol (1999) 0.93
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia (2001) 0.93
Desensitization and internalization of human and xenopus gonadotropin-releasing hormone receptors expressed in alphaT4 pituitary cells using recombinant adenovirus. Endocrinology (2000) 0.92
Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med (1987) 0.91
Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol (1998) 0.91
Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J Neurosci (1997) 0.90
The tail of the gonadotrophin-releasing hormone receptor: desensitization at, and distal to, G protein-coupled receptors. Mol Cell Endocrinol (1999) 0.90
NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol (1998) 0.90
Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia (1995) 0.90
Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia (2004) 0.89
Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood (1996) 0.89
Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol (1993) 0.89
STI prevention and the male sex industry in London: evaluating a pilot peer education programme. Sex Transm Infect (2000) 0.88
Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur J Neurosci (1997) 0.88
Aldose reductase inhibitors and diabetic complications. Pharmacol Ther (1992) 0.88
Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res (1994) 0.88
Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes (1990) 0.88
Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia (1989) 0.88
Can neuronal smooth endoplasmic reticulum function as a calcium reservoir? Neuroscience (1978) 0.88
Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol (1991) 0.87
Two populations or granular vesicles in constricted post-ganglionic sympathetic nerves. J Physiol (1975) 0.87
Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst (1999) 0.87
Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro. Brain Res (1982) 0.87
Amino acids in 'light' and 'heavy' synaptosome fractions from rat olfactory lobes and their release by electrical stimulation. J Neurochem (1976) 0.87
Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. J Neurochem (1984) 0.87
Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia (1998) 0.87
Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res (1995) 0.87
Independent learning packages (audio tape/pamphlet) for a course in cell excitation: evidence that they can be at least as effective as conventional lectures. Med Educ (1979) 0.87
Reciprocal regulation of tachykinin- and vasoactive intestinal peptide-gene expression in rat sensory neurones following cut and crush injury. Brain Res (1989) 0.86
Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem (1995) 0.86
Regeneration of primary afferent neurons containing substance P-like immunoreactivity. Brain Res (1986) 0.86
Interaction between fluconazole and rifampicin. BMJ (1990) 0.85
Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3. Brain (2003) 0.85
Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Diabetes (1986) 0.85
Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Diabetes (1985) 0.85
Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci (1989) 0.85
Effect of dibutyryl-cyclic AMP and dexamethasone on noradrenaline synthesis in isolated superior cervical ganglia. J Neurochem (1974) 0.85
Proceedings: The noradrenaline concentration and the cholinesterase activity of the separated longitudinal and circular layers of muscle of the guinea-pig vas deferens. Br J Pharmacol (1974) 0.85
Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog Neurobiol (1996) 0.85
Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes. Brain Res Mol Brain Res (2004) 0.84
Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Diabetologia (1987) 0.84
Axonal transport of activating transcription factor-2 is modulated by nerve growth factor in nociceptive neurons. J Neurosci (1999) 0.84
Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia (1988) 0.84
Effect of exercise on simple reaction times of recreational athletes. Percept Mot Skills (1994) 0.84
Substance P in the mouse cornea: effects of chemical and surgical denervation. Neurosci Lett (1982) 0.84
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. J Auton Nerv Syst (1996) 0.83
An analysis of the response of the perfused vas deferens of the rat to field stimulation [proceedings]. Br J Pharmacol (1978) 0.83
GABAB receptor modulation of the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol (1991) 0.83
Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes. J Neurol Sci (1996) 0.83
Cycloheximide-sensitive synthesis of substance P by isolated dorsal root ganglia. Nature (1980) 0.83
Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity. J Neurochem (1988) 0.83
Autonomic neuropathy in the alloxan-diabetic rat. J Auton Pharmacol (1983) 0.83
Biosynthesis, axonal transport and turnover of neuronal substance P. Ciba Found Symp (1982) 0.83
Multiple personality disorder and borderline personality disorder. Distinct entities or variations on a common theme? Ann Clin Psychiatry (1993) 0.82
alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett (1997) 0.82
Effects of synthesis inhibition and nervous activity on concentrations of neuronal substance P. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.82
The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats. Br J Pharmacol (1992) 0.82
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett (1982) 0.82
Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukot Essent Fatty Acids (1993) 0.82
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol Brain Res (2000) 0.82
Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res (2000) 0.82
Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin. Diabetes (1988) 0.82